Cargando…
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
Autores principales: | Kim, Kibem, Skora, Andrew, Li, Zhaobo, Tam, Ada, Diaz, Luis, Papadopolous, Nickolas, Blosser, Lee, Kinzler, Kenneth, Vogelstein, Bert, Zhou, Shibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292576/ http://dx.doi.org/10.1186/2051-1426-2-S3-P267 |
Ejemplares similares
-
An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation
por: Miller, Michelle S., et al.
Publicado: (2019) -
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints
por: Losa, Nicolas L, et al.
Publicado: (2015) -
FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
por: Kinde, Isaac, et al.
Publicado: (2012) -
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
por: Diaz, Luis A., et al.
Publicado: (2012) -
An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
por: Cook, Ashley L., et al.
Publicado: (2022)